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Using Respiratory Variations of Plethysmographic Waveforms to Track Changes in Intravascular Volume 
during Hemodialysis 
Nyasha George, George Attif, Beshoy Esmat, Kirk Shelley, David Silverman, Aymen Alian.  
Department of Anesthesiology, Yale University, School of Medicine, New Haven, CT. 
Whereas dynamic indices have been shown to accurately predict volume status in mechanically ventilated patients, 
we still lack a reliable noninvasive means of intravascular volume status assessment in spontaneously breathing 
patients. The present study was undertaken to determine the impact of incentive spirometry (IS) on 
plethysmographic (PPG) waveforms in spontaneously breathing end stage renal disease (ESRD) patients. 
Furthermore, the impact of ultrafiltration on plethysmographic waveform variability in spontaneously breathing 
patients with and without incentive spirometry was analyzed. 
With IRB approval, data were collected and analyzed for 44 hemodialysis cases. PPG waveforms were recorded at 
100 Hz with a data acquisition system (S5 Collect) with patients first spontaneously breathing (SB) and then 
performing IS breathing. The waveforms were analyzed (spectrum, 4K, Hamming, Amplitude density) using Chart 
software (ADInstruments). Data were presented as mean ± SD. The results were compared using the 2-tailed t-test, 
and P < 0.05 was considered statistically significant. 
There was significant increase in the PPG DC with the use of IS, p value = 0.0000002. The average PPG DC at 
baseline was 1.06 ± 0.82 with SB while average PPG DC with IS  was 3.54 ± 1.58, with percent change of  234% 
increase from baseline. Similarly, at the end of dialysis, a comparison between SB and IS showed a 203% change in 
the PPG DC value (1.92±1.03 with SB versus 5.819±2.84 with IS, p=0.000023).  Whereas IS was consistently 
associated with a significant increase in PPG DC at the end of dialysis, SB was not associated with a significant 
increase in PPG DC at the end of dialysis when the ultrafiltrate rate exceeded 1000cc/hr. 
Dynamic noninvasive hemodynamic evaluation has been shown to be more accurate than conventional 
hemodynamic static pressures; among the noninvasive methods is the PPG. This study showed a significant increase 
in PPG DC amplitude density during IS, and a significant increase in PPG DC during IS at the end of dialysis as 
3	  
	  
compared to the beginning. This suggests that IS can be used as a tool to track changes in PPG DC variability in 
spontaneously breathing ESRD patients undergoing dialysis.  
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Normal Physiologic Responses to Hypovolemia 
The normal physiologic response to hypovolemia is comprised of three main mechanisms aimed 
at: (1) decreasing venous capacity (2) increasing total peripheral resistance, and (3) increasing 
cardiac chronotropy and inotropy 1. 
(1) Decreased venous capacity 
At baseline, a significant portion of the total blood volume remains sequestered in the high 
capacitance venous system. During the normal response to hypovolemia, this sequestered 
volume is mobilized centrally, which helps to mitigate the decrease in venous return and 
thus maintain cardiac filling and, subsequently, cardiac output. There are two proposed 
mechanisms by which this decrease in venous capacity occurs: 
I. The DeJager-Krogh phenomenon. In this mechanism, hypovolemia stimulates constriction 
of the resistance vasculature (arterioles), which in turn has the downstream effect of 
decreasing blood flow to a capillary bed. The decreased regional blood flow results in a 
decrease in distending pressure that the blood is able to exert on the walls of the veins. As 
such, there is a passive recoil of the veins, which reduces venous capacity and mobilizes the 
sequestered blood towards the heart2. This phenomenon is visually depicted on page 234 of 
the journal article entitled ‘Dialysis Hypotension: A hemodynamic analysis’1. The two 
vascular beds that have been shown to contribute most significantly to augmenting venous 
return via this mechanism of decreasing venous capacitance are the splanchnic and the 
cutaneous circulations.  




(2) Increase in Total Peripheral Resistance 
The increase in total peripheral resistance that normally occurs with hypovolemia has 
multiple functions.  
I. Vasoconstriction in the arterioles that supply the kidneys and the muscles, allows for 
preferential diversion of the depleted blood volume to crucial organs such as the heart 
and the brain.  
II. The increase in peripheral resistance in the splanchnic and cutaneous circulation (via 
arteriolar constriction) serves to passively mobilize blood initially sequestered in the 
venous circulation, thereby helping to maintain venous return to the heart 1.  
(3) Increased Cardiac Chronotropy and Inotropy 
In hypovolemia, there is an early increase in heart rate, which later returns to baseline or 
sub-baseline levels. Cardiac contractility also increases during hypovolemia. 
Notwithstanding this, cardiac output appears to be limited by the amount of blood returning 
to the heart, while optimization of the heart’s pumping performance plays a very minimal 




Intra-Dialysis Hypotension  
Symptomatic intra-dialysis hypotension (IDH) is a major cause of morbidity in hemodialysis 
patients2. IDH is most commonly defined as a drop in SBP of ≥30 mmHg, or a drop in MAP of 
≥10 mmHg, and occurs in 10-30% of dialysis treatments4. Furthermore, there is a subset of 
dialysis patients who are plagued by IDH in at least 50% of their treatments4. Risk factors 
predisposing patients to more frequent IDH events are summarized in the table 1. 
















Patient Comorbidities that Increase Risk for Intradialytic 
Hypotension  
Physiology of elderly patients 
DM 
     Cardiac Disease 
    Autonomic Dysfunction 
Primary or Secondary Autonomic Neuropathies 
Structural Heart Disease 
     Left Ventricular Hypertrophy 
     Diastolic Dysfunctions 
     Dilated Cardiomyopathy 
     Systolic/Diastolic Dysfunction 
     Right Heart Failure/Pulmonary Hypertension 
Cardiac Arrhythmias 
     Atrial fibrillation 
     Ventricular ectopy 
Pericardial Disease 
     Pericardial effusion 





The symptoms of IDH stem from decreased perfusion pressure which causes end-organ 
ischemia. Hypoperfusion of the musculature manifests as cramps, hypoperfusion of the GI tract 
presents as nausea and vomiting, and hypoperfusion of the brain results in symptoms of blurred 
vision, dizziness, fatigue, and weakness2,4. Needless to say, these symptoms make for a very 
unpleasant dialysis treatment, and can result in their early termination. The more serious 
potential sequelae of IDH events include cerebrovascular insufficiency (syncope, TIA, stroke, 
seizure), and cardiac instability (acute myocardial infarction, arrhythmias). In the long term, 
recurrent episodes of IDH increase the risk of asymptomatic cardiac ischemia, and heart damage. 
Repeated IDH is also associated with an elevated risk of vascular access thrombosis and a 
decline in the patient’s remaining renal function 5. Overall, recurrent IDH may be linked to an 
increased mortality rate5,6.  
Pathophysiology of IDH in ESRD Patients  
The pathophysiology of dialysis-induced hypotension can be conceptualized as a multifactorial 
process3,4.  
1) The rapid or excess removal of ultrafiltrate, with inadequate replacement of the 
intravascular compartment with fluid from the extra vascular space. This ultimately 
results in intravascular volume depletion. However, intravascular volume depletion alone 
is not sufficient to cause hypotension, as there are patients who are able to maintain their 
blood pressures despite a reduction in their circulating blood volume 3.  
2) A concomitant failure of the cardiovascular system to mount an adequate compensatory 
response to the volume loss3,4. Many dialysis-dependent patients exhibit aberrant 
responses to volume removal/ultrafiltration. As such, these ESRD patients are less well 
able to maintain their blood pressures in states of decreased blood volume. These 
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anomalous responses can be grouped into the following categories: 
I. Failure to reduce venous capacity 
A. Autonomic neuropathy:  results in failure to recruit sufficient venous-sequestered 
blood into the central circulation to offset the decrease in blood volume. 4.  
B. Vasodilation: warming of the body’s core that occurs with hemodialysis triggers a 
thermoregulatory vasodilation of cutaneous blood vessels, which can further 
exacerbate the failure to mobilize blood centrally4.  
II. Failure to Increase Total Peripheral Resistance 
A. Autonomic neuropathy: studies have shown that many ESRD patients, and 
particularly those with comorbid diabetes, have significant impairments of their 
autonomic nervous systems7. For instance, baseline baroreflex impairments has 
been shown to distinguish hypotension-prone patients from their hemodynamically 
stable counterparts8. Uremia may also contribute significantly to autonomic 
dysfunction7. The consequence of this autonomic impairment is that these patients 
are unable to appropriately constrict their resistance vessels to increase SVR, thus 
making them susceptible to a drop in blood pressure with volume depletion. 
B. Imbalance of other mediators: disequilibrium of endothelin-1 (vasoconstrictive 
factor) and nitric oxide (vasodilatory factor), elevated adenosine levels, impaired 
norepinephrine release, inadequate vasopressin release in response to volume 
removal, and elevated levels of endotoxin4. 
III. Heart Disease 
ESRD patients do not have “normal hearts” and may not be able to respond 
appropriately to intravascular volume removal. Blood pressure maintenance may 
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become dependent upon increases in the heart rate and contractility especially in the 
face of an inappropriate reduction in SVR. For instance, long standing hypertension 
and/or hypervolemia, AV shunts, and anemia, result in left ventricular hypertrophy 
(LVH) in more than 70% of dialysis-dependent patients 4,9. Systolic or diastolic 
dysfunction, the sequelae of LVH, has been shown to put ESRD patients at risk for 
hypotension4. It has also been shown that uremic patients exhibit impairments in 
heart rate responses to Valsalva, and other maneuvers that induce blood pressure 
changes1.  
Current Treatment Strategies in the management of IDH 
Current strategies targeting a reduction of IDH events include a combination of patient-focused 
and dialysis-focused interventions. 
1)  Lowering the temperature of the dialysate helps to prevent the increase in core body 
temperature that occurs with dialysis, and thus reduces the cutaneous vasodilation that shunts 
blood away from the central circulation 2,4. Furthermore, dropping the temperature of the 
dialysate has been shown to augment baroreceptor sensitivity variability, and the peripheral 
vasoconstriction response to volume reduction4. However, caution must be exercised as 
patients may experience undesirable symptoms related to being excessively cooled4.  
2) Avoiding food ingestion before or while on dialysis also reduces the risk of IDH. This is 
because food ingestion normally causes vasodilation of the splanchnic circulation, and thus 
splanchnic venous pooling. 
3) Medical treatment directed at stimulating vasoconstriction has also been successfully utilized 
in reducing IDH. Such medications include midodrine (an alpha-1 agonist), sertraline, and L-
carnitine. In one study, the intravenous administration of AVP improved blood pressure 
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during hemodialysis 4. Other medications that have been studied and shown to have a 
positive effect on the frequency of IDH events include adenosine antagonists, hypertonic 
saline, and glucose4.  
4) Dialysate electrolyte concentrations can also be adjusted to reduce the risk of IDH. For 
instance, use of higher Ca2+ concentrations in the dialysate help to optimize cardiac function 
2,4, an important consideration for patients with LVH and concomitant heart failure. 
Historically, increasing the dialysate sodium concentration has also led to improved 
intradialysis hemodynamics2,4. Higher levels of sodium in the dialysate prevent the drop in 
plasma osmolality that accompanies rapid solute removal. This maintenance of extracellular 
sodium in turn facilitates the diffusion of intracellular water to the extracellular space4.  
5) Using lower ultrafiltration rates (and thus lengthening treatment time), or increasing the 
frequency of dialysis to daily treatments, would decrease the problem of IDH. This has in 
fact been proven true in multiple studies10,11 The risk of IDH increases when patients 
accumulate large interdialytic weight gain, thus necessitating exuberant ultrafiltration rates to 
return the patient back to his dry weight. It follows therefore that more frequent and longer 
dialysis treatments could be beneficial in reducing IDH events, but this is unlikely practical 
given the inconvenience and cost of increasing treatment times or frequency.  
While the aforementioned treatment strategies have certainly helped to reduce the incidence of 
IDH, it still remains the most commonly encountered problem in hemodialysis4. None of the 
interventions described above effectively target the primary inciting event in IDH: the excessive 
or rapid removal of ultrafiltrate. Currently, the amount of ultrafiltrate to be removed in any one 
session is calculated by subtracting the patient’s ‘dry weight’ from the patient’s current weight. 
This method of prescribing the ultrafiltrate is completely reliant on the assumption that the dry 
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weight assigned to the patient truly reflects a euvolemic state. In practice, however, the dry 
weight is determined by trial and error, and is the weight at which the patient has neither signs 
nor symptoms of volume depletion or volume excess4. The eradication of IDH is dependent upon 
the development of a more objective predictor of volume status that can sensitively track changes 
in volume status during ultrafiltration.  
Assessment of Volume Status: 
A- Using Traditional Clinical Signs 
The traditionally taught clinical signs of hypovolemia (whether due to dehydration or volume 
depletion) which include hypotension, tachycardia, postural vital sign instability (an increase in  
pulse of >30 beats/min, or a BP drop >20 mmHg), and increased capillary refill time, are 
notoriously insensitive markers, especially when the degree of volume loss is small or moderate 
in quantity12. For example, only 1 in 5 patients exhibits postural pulse increase (from supine to 
standing) of >30 beats/minute, or severe dizziness preventing standing, after a moderate blood 
loss of 450-630 mL12 . The sensitivity of these signs increases to 97% for patients with a large 
volume loss of 630-1150 ml12. Postural hypotension (defined as a decrease in SBP of >20 mm 
Hg) has even poorer sensitivity. In patients <65 years, it has a sensitivity of 9% for 450-630 mL 
of blood loss, and for patients >65 years of age, it has a sensitivity of 27% for 450-630 mL of 
blood loss12. These values correspond closely to the false positive rates in the same age groups 
(10% for patients <65 years of age, and 28% for patients >65 years of age), making the use of 
postural hypotension a very poor tool in the detection of moderate amounts of blood loss 12.  
There appears to be limited data on the sensitivity of postural hypotension with larger blood 
volume losses of 630-1150 mL. Similarly, static measurements of supine blood pressure and 
heart rate are very insensitive to (but fairly specific for) blood loss.  
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B- Invasive Static Pressures  
Invasive measures of CVP and pulmonary artery occlusion pressure, many studies have shown 
that these static measurements are not helpful in determining fluid status, and as such, it is no 
longer recommended that they be used to guide fluid management13. 
The Plethysmographic Waveform 
The peripheral plethysmographic waveform (PPG) is a waveform obtained from the pulse 
oximeter, the ubiquitous clinical monitoring device that is comprised of a light source and a 
detector. The detector may be positioned either directly across from the light source (as in the 
finger plethysmography) or next to the light source (as in forehead plethysmography). The PPG 
waveform is determined by the equation known as Beer’s law, which states the following:  
A total= E1C1L1 + E2C2L2+ …+ EnCnLn 
where  
A= Absorbance at a particular wavelength 
E=extinction coefficient (absorbency) 
C=concentration  
L= path length between the light source and the detector  
The PPG waveform represents the changes in blood volume over time in a tissue of interest 
(usually the finger or the earlobe) to which the pulse oximeter is applied14. The source of this 
waveform is most likely the “point of maximal pulsation”15  of peripheral arterioles, just 
proximal to the point at which pulsatile blood flow is converted to smooth capillary flow. 
The PPG waveform was initially conceptualized as comprising of an invariant “DC” component 
(which was thought to represent a constant volume of venous blood and tissue), and a pulsatile 
“AC” component (which reflected changes in arterial blood volume as affected by cardiac 
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activity). The DC component can be isolated from the original waveforms by applying a low 
pass filter, and the AC component can be similarly isolated by applying a high pass filter as 
shown in (figure 1).  
 
Figure 1. PPG DC and PPG AC components illustrated. The PPG AC component is isolated from the original 
waveform by applying a high pass filter, whereas the PPG DC component is obtained by applying a low pass filter. 
The data used to generate this plot are the original results of this thesis work. 
The term “DC component” turns out to be somewhat of a misnomer. This component is hardly 
invariant, but instead fluctuates under the effects of respiration, vasomotor activity, 
thermoregulation, and other influences14. Similarly, the AC component not only reflects cardiac 
activity, but also shows a slower variation that is also under the influence of respiration16.The 
respiratory-induced cyclic changes in both the DC and AC components of the plethysmograph 
are illustrated in figure 2, and will be further discussed in the section on ‘respiratory variation of 




Figure 2. Impact of respiration on the plethysmographic waveform. Top shows the airway pressure versus time, 
where each deflection from zero represents an inhalation using incentive spirometry. The bottom plot shows the 
changes in the DC component and the AC component of the plethysmograph. An overlay of these two plots 
illustrates the influence of respiration on PPG parameters. The data used to generate this plot are the original results 
of this thesis work. 
It is worth mentioning that the PPG signal visualized on most commercial pulse oximeters is the 
end result of significant signal processing.  Typically, it is only the AC component of the 
plethysmograph that is displayed, whereas the DC component is routinely eliminated via an 
autocentering function15.  Additionally, an autogain function is used to maximize the amplitude 
of the AC component, thereby maximizing the size of the waveform for optimum visibility on 
the display screen17. The data processing pathway that is involved in generating the displayed 
PPG waveform is pictorially represented in the journal article ‘Photoplethysmography and its 
application in clinical physiological measurement’14. Utilization of the plethysmograph for 
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research purposes necessitates the removal of autogain and autocentering functions such that 
critical data are not lost.  
There are many factors both intrinsic and extrinsic to the subject that can cause variability in the 
plethysmograph waveform. For one, the pulse oximeter waveform is responsive to the autonomic 
nervous system. The degree of impact of the sympathetic nervous system on the PPG waveform 
is commensurate with the amount of sympathetic nervous innervation in the tissue of interest; the 
sympathetic innervation of the cutaneous blood vessels of the finger is greater than that of the 
earlobe, and correspondingly the finger-derived PPG waveform is more sensitive to alterations in 
the sympathetic nervous system than the earlobe-derived PPG waveform 15. At the same value of 
cardiac output, the amplitude of the PPG waveform depends on the degree of vascular 
distensibility.  Thus in conditions of high sympathetic tone, peripheral cutaneous vascular 
compliance is low, the amplitude of the PPG waveform decreases with respect to baseline15. 
Conversely, when the vessels are more compliant, the amplitude of the PPG waveform increases 
with respect to baseline. Table 2 gives a short list of the other determinants of the PPG 
amplitude; this list is by no means exhaustive. 
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Factors Affecting Pulse Oximeter Waveform Amplitude 
Increased Amplitude due to Vasodilation 
1. Pharmacological-nitroprusside 
2. Physiologic-warming, sedation 
3. Anesthetic-regional sympathetic blocks (spinal and epidural) 
Decreased Amplitude due to Vasoconstriction 
1. Pharmacological-phenylephrine, ephedrine 




Respiratory Variation of the PPG Waveform as a Predictor of Fluid Responsiveness 
Fluid responsiveness is commonly defined as a >15% increase in stroke volume in response to 
administration of a 500cc bolus of fluid.	  Another way of thinking about this is that fluid 
responsive patients are operating on the steep portion of the Frank-Starling curve (figure 3), and 
therefore an increase in venous return translates into an increase in cardiac output. Conversely, 
fluid non-responders are those patients who are operating on the flat portion of the Frank Starling 
curve, and for whom fluid administration will simply cause tissue edema. 
 
Figure 3. The Frank Starling Curve. Fluid responsive patient operate on the steep portion of the Frank Starling 
curve, and there is a greater than 15% increase in stroke volume from the point a’ to the point b’.  Fluid non-
responders however, operate on the flat portion of the Frank Starling curve, where point b = point a18 
Functional Hemodynamics 
To understand the physiologic basis of dynamic fluid indices based on heart lung interactions, 
one must first understand two concepts that relate to the heart. 
The first concept is that of the parallel diastolic ventricular interdependence19; the right and left 
ventricles of the heart are mechanically coupled due to their sharing of a common pericardial sac, 
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common circumferential fibers, and a common septum. The consequence of this mechanical 
coupling is a phenomenon known as the direct ventricular diastolic interdependence in which the 
diastolic filling of one ventricle compromises the filling of the contralateral ventricle by directly 
affecting its compliance and shape19. 
The second concept is that of the series ventricular interdependence19, which states that after a 
lag of a few heart beats (corresponding to the pulmonary transit time), changes in the output of 
the right ventricle must necessarily be propagated forward to the left ventricle, thus affecting the 
left ventricular preload19. In positively ventilated patients, each “inspiration” introduces positive 
pressure into the thorax, which compresses the pulmonary vasculature temporarily augmenting 
arterial flow out of the thorax and into the left atrium, while also reducing the left ventricular 
afterload19. This results in an immediate and transient increase in left ventricular stroke volume 
during inspiration. Simultaneously, the positive pressure breath also temporarily impedes venous 
return to the heart. Given the series interdependence of the two ventricles, this reduction in 
venous return is “seen” by the left ventricle after a few heartbeats (corresponding to the transit 
time through the pulmonary vasculature), and results in a temporary reduction in stroke 
volume20.In low intravascular volume states (when the patient is preload dependent and therefore 
operating on the steep portion of the Frank Starling curve), this respiratory effect on the 
cardiovascular system is particularly pronounced, as the heart’s stroke volume is sensitive to the 
ventilation-induced changes in venous return. Conversely, in euvolemia or hypervolemia, when 
the patient is operating on the flat portion of the Frank-Starling curve, the respiratory effect on 
the cardiovascular system is minimal resulting in smaller impacts on the stroke volume. Thus 
there is a greater respiration-induced variation in stroke volume with hypovolemia as compared 
to euvolemia and hypervolemia. It has already been well established that for mechanically 
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ventilated adult patients with no cardiac arrhythmias receiving more than 8ml/kg of tidal volume, 
the volume dependent respiratory variation in left ventricular stroke volume corresponds to 
ventilation-induced changes in systolic arterial pressures 16,21 . Numerous studies shown that the 
respiratory-induced variation in the arterial pressure waveform in ventilated patients (fig 4) is a 
reliable predictor of fluid responsiveness in the absence of abnormal heart rhythms16,21,22 
	  
Figure	  4.	  Influence of positive pressure ventilation on arterial blood pressures in volume-controlled ventilation. 
ΔUp is the increase in systolic arterial blood pressure during expiration with respect to the systolic arterial blood 
pressure during a period of apnea. ΔDown is the decrease in systolic arterial blood pressure during positive pressure 
inspiration with respect to its value during a period of apnea. Both ΔUp and ΔDown require a period of apnea to 
obtain a reference value for their measurement. PPmin and PPmax are the minimum and maximum values of pulse 
pressure over the respiratory cycle. Higher values of ΔDown and PP (PPmax-PPmin) are predictive of hypovolemia. 
Subsequent to the establishment of this relationship between fluid responsiveness and respiratory 
variability in arterial pressure parameters, researchers began to focus on the striking resemblance 
between the arterial pressure waveform and the plethysmograph 16,21,23, in the hope that the latter 
could be used in noninvasive fluid status monitoring. For instance, Shamir et al compared 
changes in the arterial pressure waveform and the plethysmographic waveform after subjects 
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underwent 10% loss of total blood volume, and again with volume replacement16. These authors 
found significant correlations in changes that occurred in the plethysmographic and arterial 
pressure waveforms with volume depletion16.  In a second study, the plethysmographic 
variability index (PVI) (an automated value that indicates the degree of variability in the 
plethysmographic waveform over the respiratory cycle) was found to be highly accurate in 
predicting fluid responsiveness immediately after intubation during mechanical ventilation and 
before the beginning of surgery, and fairly accurate in predicting fluid responsiveness during 
surgery24.  This work corroborated similar findings that had been published on the use of the PVI 
to predict fluid responsiveness in patients during heart25 and major abdominal surgeries26. 
There are several points to be noted on the current body of research that relates fluid 
responsiveness with respiratory variability in the plethysmograph. These points are delineated 
below. 
1. Most studies on the use of dynamic indices to predict fluid status have been done on 
mechanically ventilated patients. As previously mentioned, the pleth variability index has 
only been proven to have predictive value in patients ventilated with a tidal volume of 
8ml/kg, and in the absence of cardiac arrythmias. There is a relative dearth of information 
on how these concepts may be applied to predict fluid responsiveness in spontaneously 
breathing patients. The few studies that have been published on the use of dynamic 
indices to predict fluid responsiveness in spontaneously breathing patients have reported 
mixed results.  For instance, in one study the pulse pressure variation (ΔPP) was not 
found to be predictive of preload responsiveness in spontaneously breathing patients27,28.  
In another study, the authors compared using ΔPP  (respiratory change in arterial pulse 
pressure) and ΔSP (respiratory change in arterial systolic pressure) during spontaneous 
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breathing and during Valsalva maneuvers to predict fluid responsiveness in non-
ventilated patients29.  The authors found that the dynamic indicators, ΔPP and ΔSP were 
significantly higher in fluid responders than non-responders, and predicted fluid 
responsiveness with high specificity. However, the sensitivity of ΔPP and ΔSP was very 
low. For instance, a cutoff value of 12% for ΔPP was associated with a 92% specificity 
but a 63% sensitivity29.  In comparison with mechanically ventilated patients, the 
sensitivity of ΔPP  in this study of spontaneously breathing patients was much 
lower29.There are several posited explanations for why this relationship breaks down in 
non-ventilated patients. For one, the intrathoracic pressure changes associated with 
spontaneous respiration may be insufficient stress on the system to have a measurable 
impact on venous return and thus left ventricular stroke volume29.  Additionally, 
spontaneous breathing is associated with significant breath-to-breath variability in tidal 
volume, and ΔPP is influenced by tidal volume27. Thus the variability in tidal volume 
associated with spontaneous breathing may mask the degree of pulse pressure variation.  
As for Valsalva maneuvers, the mechanism of exhaling against a closed airway may 
change the afterload seen by the left and right ventricles, which in turn complicates the 
relationship between respiration and stroke volume 27. 
2. The published literature has focused almost exclusively on the pulsatile ‘AC’ component 
of the plethysmograph to predict fluid responsiveness. However, emerging research from 
our lab suggest that the largely ignored ‘DC’ component (which reflects the venous 
circulation) may be more sensitive to changes in fluid status, and begins to exhibit 
changes earlier in volume loss than the AC component. In a study of eleven children 
scheduled for spinal fusion surgery , the effect of blood loss and fluid boluses on the PPG 
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and arterial waveforms was investigated30. The pilot study found that parameters related 
to the PPG DC modulation (ie the slow, ventilation-induced modulation of the PPG DC 
component) were the only parameters that changed significantly with blood loss, and 
again with fluid resuscitation. Conversely, parameters related to the AC modulation 
(respiratory modulation of the PPG amplitude) showed significant changes with blood 
loss only, but not with fluid resuscitation. These preliminary results suggest that the 
respiratory effects the DC component (ie the venous side) are more sensitive to fluid 
changes than the respiratory AC modulation (ie the arterial side). Consistent with the 
poor predictive ability of vital signs, the blood pressure and heart rate showed no 
significant changes with either blood loss or volume replacement30. 
3. Furthermore, despite the obvious advantages, these principles of respiratory variability in 
the plethysmograph have never been used to track excess or too-rapid removal of 




Statement of Purpose and Hypothesis   
The purpose of this study is to examine changes in the plethysmograph waveform during 
hemodialysis as a potential means of tracking progressive volume removal in non-intubated 
patients. As compared to spontaneous breathing, incentive spirometry breathing poses a greater 
challenge to the cardiovascular system by displacing more venous and arterial blood. As such, 
we hypothesized that use of incentive spirometry would amplify the respiratory modulation of 






Forty-four hemodialysis patients were recruited for this study. The study was approved by the 
IRB, and verbal informed consent was obtained from all patients. Patients were monitored using 
5-lead EKG, and a finger pulse oximeter placed on one of the upper extremity digits contralateral 
to the patient’s fistula in order to avoid arterialization of the plethysmographic waveform.  The 
autogain function of the pulse oximeter was turned off to keep the scale constant throughout the 
study.  At the beginning of the hemodialysis session, baseline values of the EKG, and 
plethysmograph (PPG) were recorded for 5 minutes, first with the patient spontaneously 
breathing, and then with the patient performing incentive spirometry breathing. The waveforms 
were recorded with a sample frequency of 100Hz using the data acquisition software S5 Collect. 
Baseline values of the blood pressure and heart rate were also recorded for each patient. Records 
were kept of any vasoactive medications (e.g. midodrine) administered to the patient during HD, 
as well as any symptoms (nausea, vomiting, fatigue) that prevented the patients from fully 
complying with the research protocol. A chart review was performed retrospectively to obtain 
the subjects’ demographic information such as weight, age, height, and medical comorbidities. 
Additionally, chart review of subjects’ vital signs, which were collected by nursing staff every 
15-30 minutes during dialysis, was used in order to identify any IDH episodes. 
Waveform Analysis 
All waveforms were analyzed using the LabChart data analysis software. There are two possible 
ways in which to analyze waveform data: the time domain (which describes changes in the 
waveform amplitude, width, area, upstroke, downslope,etc), and the frequency domain (in which 
the amplitude density in on the y axis is plotted versus frequency on the x axis). The time and 
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frequency domains are two different methods for analysis of the waveforms. The time domain 
has the disadvantage of being highly susceptible to movement artifact. Conversely, the frequency 
domain is a less familiar form of visualizing waveform data, but is less susceptible to movement 
artifact.  
This work uses frequency analysis of PPG waveforms. In order to generate the frequency 
domain, LabChart’s fast fourier transform function (Hamming window, 4K, 2FFT, 93.75% 
overlap) was applied to data segments of approximately 60 seconds. The fourier transform is a 
mathematical operation used to decompose the time domain waveform into the sum of 
component sinusoidal waves of varied amplitudes, frequencies, and phases. The amplitude 
densities of the component waves are then plotted against their respective frequencies to create 
the frequency domain. Thus the frequency domain allows one to visualize the contributions of 
waves of various frequencies to the original waveform. Figure 5 below illustrates the frequency 
domain of PPG waveforms.  The frequency domain was used to derive the following parameters: 
-respiratory frequency 
-amplitude density of the respiratory frequency 
-PPG DC (amplitude density of the PPG wave at the respiratory frequency, which corresponds 
to the amount of respiratory modulation of the DC component) 
-pulse/cardiac frequency 
-pulse AD (amplitude density of the PPG wave at the cardiac frequency) 
-pulse AC (amplitude density at the respiratory frequency of the PPG height wave, which 




Figure 5. PPG waveform and frequency domain.. Amplitude density of respiration and PPG DC are indicated on the 
plot. 
Statistical Analysis 
Baseline values (at the beginning of dialysis) were compared with values obtained at the end of 
hemodialysis. Also, spontaneously breathing values were compared with incentive spirometry 
values. Results were compared using the 2-tailed t-test and values of p<0.05 was considered 






Forty-four subjects were studied using our protocol described in the methods section. 23 subjects 
were of poor data quality (e.g. significant movement artifact in the plethysmographic waveform), 
and were not included in the final analysis.  Therefore, we analyzed 21 data sets for this study. 
The subjects’ demographic data and dialysis parameters are summarized in tables 3 and 4 
respectively below. Eight subjects met IDH criteria (decrease in SBP of ≥30 mmHg, or a 
decrease in MAP of ≥10 mmHg); two of these subjects (subject 16 and subject 21) received 
treatment for IDH. Subject 3 had a history of IDH and was given prophylactic midodrine both 
prior to and during the dialysis treatment in order to maintain his intradialysis blood pressures. 




Patient Demographic Data  
Parameter Values 
Age (yr) 59.9±17.16 
Male/Female (n) 14/6 (20) 
Comorbidities Diabetes Mellitus 12 
 Hypertension 12 
 Heart Disease 5 
 Liver Disease 3 

















Average Filtration Rate 
(cc/hour) 







5 N None 
6 Y None 
9 Y None 
12 N None 
13 N None 
17 Y None 









2 N None 
3 N Midodrine 
4 N None 
7 N None 
8 N None 
11 N None 
14 Y None 






1 N 1U PRBC, 1U Albumin 
10 N None 
15 N None 
16 Y Midodrine 
20 N None 
21 Y 200cc NS 
  
Table 4. Dialysis parameters for each of the twenty one cases. IDH was defined as a decrease in SBP >30mmHg or a 
decrease in MAP > 10mmHg with concomitant symptoms.  
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Hemodynamic Data 
Hemodynamic Data Grouped By Volume of Ultrafiltrate Removed and Ultrafiltration Rate 
The hemodynamic data of the 21 cases are presented in three groups based on the rate of 
ultrafiltration. By grouping the data into ultrafiltration rates, dialysis time (plotted on the x-
axis) can be used as surrogate for the volume of ultrafiltrate removed. In this way, any predictive 
vital sign trends that occur with volume removal may be elucidated. There were nonuniform 
changes in blood pressure and heart rate responses to volume removal as shown in figure 6-
8. These data are consistent with the poor predictability of vital sign data in tracking successive 
volume removal, as the presence or absence of compensatory cardiovascular mechanisms result 
in a confusing and misleading picture of vital signs with ultrafiltration. 
 





Figure.7  a-c Variations in SBP, HR, and MAP during dialysis for subjects whose rate of ultrafiltration was  500 
ml/hr >Rate<1000 ml/hr. 
 






In order to better visualize any existing trends in the hemodynamic data, the data were further 
subdivided into groups based on the amount of ultrafiltrate (UF) removed during dialysis, as 
well as the rate of ultrafiltrate removal (Rate). Again, as illustrated in figures 9-13, for each 
subcategory, there were nonsignificant changes in blood pressure and heart rate responses to 
volume removal.  
.	    
Figure. 9 a-c. Variations in SBP, HR, and MAP during Dialysis for subjects who had <1L of ultrafiltrate removed at 





Figure. 10.a-c Variations in SBP SBP, HR, and MAP during dialysis for subjects who had 1L-2L of ultrafiltrate 
removed and at a rate of <500ml/hr. 
  
Figure. 11. a-c Variations in SBP, HR, and MAP during dialysis for subjects who had 1L-2L of ultrafiltrate removed 




Figure.12 a-c Variations in SBP, HR, and MAP during dialysis for subjects who had >2L of ultrafiltrate removed 
and at a rate of 500-1000 ml/hr. 
 
Figure.13  a-c Variations in SBP, HR, and MAP during dialysis for subjects who had >2L of ultrafiltrate removed 




Incentive Spirometry Breathing Amplifies the PPG DC Value  
Compared with simple spontaneous breathing, the use of incentive spirometry (IS) breathing 
greatly enhances the respiratory-induced variability of the DC component of the plethysmograph 
(PPG DC). At the beginning of dialysis, we found that with incentive spirometry breathing there 
was an increase in the mean PPG DC value by 234% (p=0.0000002) from 1.06 ± 0.82 to 3.54 ± 
1.58 (see figure14).  
 
 
Figure 14. The effect of incentive spirometry on baseline PPG DC values. The figure illustrates that incentive 







Figure 15. The effect of incentive spirometry breathing on individual baseline PPG DC values. It is noted that the 
degree of PPG DC amplification varies by case.  
At the end of dialysis treatments, we again compared the PPG DC values for spontaneous and 
incentive spirometry breathing, and again found that incentive spirometry breathing resulted in 
an increase in the PPG DC value (fig 16). Relative to spontaneous breathing, incentive 
spirometry resulted in a 203% increase in the average PPG DC value at the end of dialysis (1.92 







Figure.16. The effect of incentive spirometry breathing on PPG DC values at the end of dialysis. The figure again 






Figure. 17. The effect of incentive spirometry breathing on PPG DC values at the end of dialysis. It is again 











Table 6. PPG DC values associated with Spontaneous Breathing and IS breathing at the end of dialysis 
 
The amplification of average PPG DC with IS breathing at both the beginning and at the end of 
dialysis suggests that incentive spirometry breathing could be utilized as a strong stimulus to 
amplify the respiratory-induced variation in the plethysmograph in the spontaneously breathing 
patient. This magnification of the PPG DC with IS breathing can facilitate the tracking of 
subsequent changes in the PPG DC value that occurs with volume removal in dialysis of the 
spontaneously breathing patient. This can be a useful test especially in the preoperative period to 
assess the volume status in ESRD patient scheduled for surgery.	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The Degree of Amplification of PPG DC with IS is Related to the Respiratory Effort 
The plastic balls located within the incentive spirometry device offer a means of measuring 
respiratory effort.  Air flow rate of 600 ml/sec corresponds to movement of one ball; 900 ml/sec 
corresponds to two balls; and 1200 ml/sec corresponds to three balls. In order to better 
understand the different degrees of IS PPG DC amplification, the data were subgrouped by the 
subjects’ respiratory efforts as represented by the average number of balls they were able to lift 
while performing incentive spirometry breathing: group 1: patient was able to lift ≤1.5 balls, 
group 2: patient was able to lift between 1.5 and 2.5 balls, and group 3: patient was able to lift 
between 2.5 and 3 balls. For each of these subgroups, we calculated the average PPG DC value 
for spontaneous breathing and IS segments respectively, as well as the percentage increase in 
PPG DC with IS breathing as shown in figure 18 and 19.  
 
Figure 18. The degree of amplification of PPG DC with varying respiratory effort in IS breathing at the beginning of 




Figure 19. The percentage change in PPG DC for ≤1.5 balls, 1.5< balls≤ 2.5, and 2.5< balls≤ 3 at the beginning. The 
average percent change in PPG DC increases with increasing respiratory effort. 
Just as a tidal volume of  > 8 ml/kg in controlled ventilation is esssential to detect volume-
induced changes in the PPG, our findings suggests that a spontaneously breathing subject has to 
move at least 1.5 balls during IS breathing to optimize the respiration-induced PPG DC changes 




Changes in PPG DC during Dialysis for SB vs. IS 
With both spontaneous breathing and incentive spirometry breathing, the average PPG DC value 
increased at the end of dialysis compared to the initial baseline value. That is, ultrafiltration in 
dialysis was associated with an increase in the respiratory-induced variability of the DC 
component of the plethysmograph, a finding consistent with our expectations based on the 
physiology of the heart-lung interaction.  
Figures 20-22 are plots of the average PPG DC value for SB at the beginning and at the end of 
dialysis. For each of the three ultrafiltration rate categories (Rate<500, 500 ≤Rate≤ 1000, and 
Rate>1000), the PPG DC value was higher at the end of dialysis than at the beginning. This 
increase in PPG DC value was statistically significant for the Rate<500 (p=0.04), and 500 
≤Rate≤ 1000 (p=0.00352) groups, but was not statistically significant for the Rate>1000 group 






Figure  20a-b. PPG DC value at the beginning and end of dialysis with spontaneous breathing, Rate<500. The figure 
on the left shows the individual cases (n=6). The figure on the right shows the average and median PPG DC value. 
The PPG DC value at the end of dialysis is greater than that at the beginning of dialysis. 
 
Figure 21a-b. PPG DC value at the beginning and end of dialysis with spontaneous breathing, 500≤Rate≤1000. The 
figure on the left shows the individual cases (n=7). The figure on the right shows the average and median PPG DC 




Figure 22a-b. PPG DC value at the beginning and end of dialysis with spontaneous breathing, Rate>1000 The figure 
on the left shows the individual cases (n=3). The figure on the right shows the average and median PPG DC value. 
The PPG DC value at the end of dialysis is greater than that at the beginning of dialysis, however this increase was 










The average PPG DC value for IS at the beginning and at the end of dialysis as shown in figure 
23-25. Again, for each of the three ultrafiltration rate categories, the PPG DC value was higher at 
the end of dialysis than at the beginning. This increase in PPG DC value was statistically 
significant for all three ultrafiltration rate groups. The mean, median, standard deviation, and 
p values for this data can be seen in table 8 below. 
 
Figure 23a-b. PPG DC value at the beginning and end of dialysis with IS breathing. The figure on the left shows the 
individual cases (n=6). The figure on the right shows the average and median PPG DC value. The PPG DC value at 





Figure 24a-b. PPG DC value at the beginning and end of dialysis with IS breathing. The figure on the left shows the 
individual cases (n=7). The figure on the right shows the average and median PPG DC value. The PPG DC value at 
the end of dialysis is greater than that at the beginning of dialysis. 
 
 
Figure 25a-b. PPG DC value at the beginning and end of dialysis with IS breathing. The figure on the left shows the 
individual cases (n=3). The figure on the right shows the average and median PPG DC value The PPG DC value at 
the end of dialysis is greater than that at the beginning of dialysis. 
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Table 8. PPG DC for Incentive Spirometry Breathing at the Beginning and End of Dialysis. 
 
Therefore, our study suggests that incentive spirometry breathing can be used to reliably track 
changes in the PPG DC value that occurs with volume removal during dialysis. In each of the 
three ultrafiltrate rate categories, there was a statistically significant increase in the PPG DC 
value associated with IS breathing from the beginning to the end of dialysis. Conversely, 
spontaneous breathing resulted in statistically significant increases in PPG DC in the two slower 
ultrafiltration rate categories, but did not result in a statistically significant increase in the 
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Rate>1000 category. We had anticipated that the percentage increase (from beginning to end) in 
PPG DC with IS breathing would be greater with SB for all three ultrafiltrate rate categories. 
However, our results showed the converse pattern: for Rate <500cc/hr, there was a 129% 
increase (from beginning to end) in PPG DC with SB compared to an 84% increase with IS; for 
500≤ Rate≤1000 there was a 176% increase in PPG DC with SB compared to a 103% increase 
with IS; and for Rate > 1000cc/hr there was a 76% increase in PPG DC with SB compared to an 






The results of our study clearly illustrate the poor sensitivity and indeed the very confusing 
picture of vital signs during ultrafiltration over the time course of dialysis treatments. Thus vital 
sign data does not allow us to accurately track volume removal in dialysis patients. And yet 
ironically enough, vital sign monitoring and symptomatology remain the primary means of 
assessing patients during dialysis. This discrepancy serves as justification for our investigation 
into the potential use of the IS induced changes in PPG DC value for tracking the course of 
dialysis ultrafiltration. 
We found that on average, and in individual cases, IS breathing amplified the PPG DC value 
compared to spontaneous breathing. Furthermore, the degree of PPG DC amplification with IS 
breathing depended on the respiratory effort exerted by the subject: our data suggests the subject 
should move at least 1.5 balls during IS breathing to optimize respiration-induced PPG DC 
changes via our method.  
While previous studies have demonstrated the superiority of dynamic indices for tracking 
volume status changes, none of these prior studies were successful in spontaneously breathing 
patients, nor did they utilize frequency domain analysis. The crucial difference in our experiment 
was the novel use of the incentive spirometry as a stimulus to sufficiently stress the 
cardiorespiratory system such as to facilitate measurement of the changes in PPG DC value that 
occurred with volume removal. To further drive home this point, our results showed that IS 
breathing resulted in statistically significant increases in PPG DC at the end of dialysis for all 
three ultrafiltrate rate categories. Conversely, SB was not associated with a significant change in 




1) In order to more convincingly demonstrate the potential of our method for tracking 
changes in volume status during dialysis, values need to be collected at more frequent 
intervals to assess the consistency of this trend of increasing PPG DC value with 
ultrafiltration. Initially, attempts were made to repeat all measurements at half an hour 
intervals until the patient completed hemodialysis. Unfortunately most subjects were 
unable to comply with this frequency of data collection and, as such, measurements were 
repeated at various time points and at the end of dialysis, according to the subject’s 
willingness to complete the required incentive spirometry breathing. This is one major 
limitation of the method: it relies heavily on subject motivation to perform the incentive 
spirometry breathing exercise.  
2) Also, the quality of results is dependent on the respiratory effort that the patient is able to 
exert: the greater the respiratory effort exerted, the greater the intrathoracic pressure 
changes, and the greater the change in PPG DC value with IS breathing. Encouragingly, 
we found that there was a steep learning curve associated with incentive spirometry 
breathing, as subjects were usually able to perform the task better with successive 
attempts. Thus, patients can quickly acquire the skill of adequately performing the 
incentive spirometry task.  
3) Finally, given the susceptibility of the plethysmograph to movement artifact, our results 
include only twenty-one cases, as much of the data initially collected was unusable.  Thus 
this method requires constant online monitoring of the quality of the data being collected, 
54	  
	  
and constant reminders to the subjects of the need to remain still while data are being 
collected.  
Future study: 
Rather than time in dialysis, percent of body mass removed during dialysis may have been a 
better unit for presenting this data, however, upon chart review body weight for each case was 
not available for all subjects in this study. Further analysis (time domain and frequency analysis) 
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